Callan Capital, LLC Maravai Lifesciences Holdings, Inc. Transaction History
Callan Capital, LLC
- $1.36 Billion
- Q4 2024
A detailed history of Callan Capital, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Callan Capital, LLC holds 14,000 shares of MRVI stock, worth $64,120. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,000Holding current value
$64,120% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRVI
# of Institutions
228Shares Held
140MCall Options Held
237KPut Options Held
19.4K-
Gtcr LLC20.2MShares$92.3 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$64.2 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$54.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$44.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$38.3 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $602M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...